Ingrezza and Cardiac failure congestive - a phase IV clinical study of FDA data

Summary:

Cardiac failure congestive is reported as a side effect among people who take Ingrezza (valbenazine tosylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Seroquel, and have Tardive dyskinesia.

The phase IV clinical study analyzes which people have Cardiac failure congestive when taking Ingrezza. It is created by eHealthMe based on reports of 23,655 people who have side effects when taking Ingrezza from the FDA, and is updated regularly.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

What is Cardiac failure congestive?

Cardiac failure congestive is found to be associated with 2,157 drugs and 2,144 conditions by eHealthMe. Check the latest studies of Cardiac failure congestive.

On Jul, 28, 2026

23,655 people reported to have side effects when taking Ingrezza.
Among them, 29 people (0.12%) have Cardiac failure congestive.

Could Ingrezza cause Cardiac failure congestive?

Among these 29 people:

How long have people been on Ingrezza when they have Cardiac failure congestive? *

What is the gender of people who have Cardiac failure congestive when taking Ingrezza? *

female: 89.47 %
male: 10.53 %

What is the age of people who have Cardiac failure congestive when taking Ingrezza? *

What are other drugs people take besides Ingrezza? *

What are other side effects people have besides Cardiac failure congestive? *

Fall: 5 people, 17.24%
Drug Hypersensitivity: 4 people, 13.79%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 13.79%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 13.79%
Nightmares (unpleasant dreams): 3 people, 10.34%
Peripheral Swelling: 3 people, 10.34%
Gait Disturbance: 3 people, 10.34%
Hepatic Steatosis (fatty liver disease): 3 people, 10.34%
Hypotension (abnormally low blood pressure): 3 people, 10.34%
Kidney Infection: 3 people, 10.34%

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 21 people, 72.41%
High Blood Pressure: 3 people, 10.34%
Drowsiness: 3 people, 10.34%
Bipolar Disorder (mood disorder): 3 people, 10.34%
Stress And Anxiety: 2 people, 6.90%
Pain: 2 people, 6.90%
Insomnia (sleeplessness): 2 people, 6.90%
Depression: 2 people, 6.90%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.45%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ingrezza and have Cardiac failure congestive?

- Check whether Cardiac failure congestive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ingrezza:

Ingrezza (23,666 reports)

Browse all side effects of Ingrezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure congestive:

Cardiac failure congestive (2,157 drugs)

Browse all the conditions that are associated with Cardiac failure congestive:

Cardiac failure congestive (2,144 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valbenazine tosylate (the active ingredients of Ingrezza) and Ingrezza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.